Accuracy & Usability Study for Soberlink Cellular Device

Soberlink Healthcare LLC43 enrolled

Overview

This study scope is to validate the accuracy and usability of the Soberlink Cellular Device in comparison to a predicate device, BACtrack S80 Pro.

The purpose of this accuracy and usability study is to validate the performance of Soberlink Cellular Device in the hands of the intended (lay) users - untrained study participants who have consumed alcohol and use the Soberlink Cellular Device to measure their blood alcohol content (BAC) in comparison to a predicate device. The purpose of this document is to define how the human factors environment impacts the actual user interface design as well as how usability engineering evaluates user interface via usability objectives and usability tests. This accuracy and usability study will be performed on Soberlink Cellular Device in order to comply with FDA's Draft Guidance for Industry and Food and Drug Administration Staff, titled: Applying Human Factors and Usability Engineering to Optimize Medical Device Design, IEC 60601-1-6 (collateral standard for usability engineering of medical electrical equipment), and IEC 62366 (application of usability engineering to medical devices).

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Masking

NONE

Enrollment

Conditions

Substance Abuse

Interventions

Soberlink Cellular DeviceDEVICE

BAC breath analyzer

BACtrack S80 ProDEVICE

BAC breath analyzer

Eligibility

Sex: ALLMin age: 21 YearsMax age: 99 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Subject willing to sign an informed consent * Male or female subject between the ages of 21-99 years old * Untrained subject in the use of an Alcohol Breathalyzer * Subject willing to consume two alcoholic drinks * Subjects willing to use two Alcohol Breathalyzers * Subject willing to complete a Questionnaire Exclusion Criteria: * Subject with previous Alcohol Breathalyzer experience * Subject currently in substance use rehabilitation or post rehabilitation, or unauthorized to consume alcohol for any other reason * Subject with lung disease, or is physically unable to provide a deep lung exhalation for 4 seconds * Subject unwilling to drink two alcoholic drinks * Subject unwilling to complete a questionnaire * Subject that is non-English speaking * Subject that is a child, adolescent, or cognitively impaired. * Subject that is a pregnant and/or breastfeeding woman

Outcomes

Primary Outcomes

Validate the accuracy of the Soberlink Cellular Device in comparison to a predicate device, BACtrack S80 Pro and assessed by linear regression.

Performance validation will occur by evaluating the accuracy of the Soberlink Cellular device in the hand of intended users - untrained study participants who have consumed alcohol and use the device to measure their blood alcohol content (BAC). 40 adults will be recruited who have recently consumed alcohol. The only assistance to be provided is the labeling. No additional coaching, either written or verbal, will be provided to study participants. Participants should obtain a BAC reading with the Soberlink Cellular device, and a second BAC reading with a comparator device. The second measurement will be taken within 5 minutes of the first. A linear regression line for the comparison between results of the Soberlink Cellular device and a comparator will be made.

Time frame: Day 1

Secondary Outcomes

Validate the usability of the Soberlink Cellular Device in comparison to a predicate device, BACtrack S80 Pro and assessed by Questionnaire.

Performance validation will occur by evaluating the usability of the Soberlink Cellular device in the hand of intended users - untrained study participants who have consumed alcohol and used the device to measure their blood alcohol content (BAC). 40 adults who have recently consumed alcohol will be asked to evaluate the Soberlink Cellular device. The only assistance provided is the labeling. No additional coaching, either written or verbal, will be provided to study participants. Participants should obtain a BAC reading with the Soberlink Cellular device, and a second BAC reading with a comparator device. The second measurement should be taken within 5 minutes of the first. Following the second measurement a questionnaire will be administered to study participants to evaluate the ease of use of the Soberlink Cellular device.

Time frame: Day 1

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.